Asif Ali - Apr 18, 2023 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role
Chief Financial Officer
Signature
/s/ Matthew Gosling, Attorney-in-Fact for Asif Ali
Stock symbol
PTGX
Transactions as of
Apr 18, 2023
Transactions value $
-$27,597
Form type
4
Date filed
4/19/2023, 04:28 PM
Previous filing
Jan 18, 2023
Next filing
Jun 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTGX Common Stock Tax liability -$27.6K -1.19K -4.88% $23.21 23.2K Apr 18, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 3,437 vested restricted stock units on April 18, 2023.
F2 The shares of common stock reported on this Form 4 are subject to a lock-up agreement between the reporting person and J.P. Morgan Securities LLC, Jefferies LLC and Piper Sandler & Co., dated April 4, 2023 (the "Lock-up Date") pursuant to which the shares of common stock reported herein cannot be sold for 60 days following the Lock-up Date.